Bank7 Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Bank7 şirketinin toplam varlıkları $1.7B ve toplam özkaynağı $204.2M dır. Toplam mevduat $1.5B ve toplam krediler $1.4B dır. 5% Net Faiz Marjı kazanır. Şu anda toplam kredilerin 0.5% i olan kötü krediler için yeterli ödeneği vardır. Nakit ve kısa vadeli yatırımlar $195.4M dir.

Anahtar bilgiler

8.5x

Varlık/özkaynak oranı

5.0%

Net faiz marjı

Toplam mevduat	US$1.52b
Kredi/mevduat oranı	Uygun
Batık krediler	0.5%
Sorunlu krediler için ayrılan karşılık	Yeterli
Cari oran	Düşük
Nakit ve eşdeğerleri	US$195.44m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Bank7 Corp: Earnings Uptrend To Take A Break; Adopting A Hold Rating

Sep 10

Bank7 (NASDAQ:BSVN) Is Increasing Its Dividend To $0.24

Jul 30

Increases to CEO Compensation Might Be Put On Hold For Now at Bank7 Corp. (NASDAQ:BSVN)

May 09

Bank7 (NASDAQ:BSVN) Has Announced That It Will Be Increasing Its Dividend To $0.16

Jun 13

Here's Why We Think Bank7 (NASDAQ:BSVN) Might Deserve Your Attention Today

Mar 14

Bank7 (NASDAQ:BSVN) Will Pay A Larger Dividend Than Last Year At $0.16

Dec 08

Bank7's (NASDAQ:BSVN) Shareholders Will Receive A Bigger Dividend Than Last Year

Nov 22

Bank7 (NASDAQ:BSVN) Is Paying Out A Dividend Of $0.12

Sep 11

Bank7 declares $0.12 dividend

Sep 08

Bank7 GAAP EPS of $0.76 in-line, revenue of $16.48M beats by $0.31M

Jul 27

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Finansal Kurumlar Analizi

Varlık Seviyesi: BSVN 'nin Varlık/Özsermaye oranı ( 8.5 x) düşüktür.

Kötü Krediler İçin Ödenek: BSVN yeterli kötü krediler için bir ödeneği var ( 231 %).

Düşük Riskli Yükümlülükler: BSVN 'un yükümlülüklerinin 99% 'i esas olarak düşük riskli finansman kaynaklarından oluşmaktadır.

Kredi Seviyesi: BSVN Kredi/Varlık oranı açısından uygun bir seviyeye sahiptir ( 82% ).

Düşük Riskli Mevduatlar: BSVN 'nin Kredi/Mevduat oranı ( 93% ) uygundur.

Kötü Kredilerin Seviyesi: BSVN uygun düzeyde kötü krediler içeriyor ( 0.5 %).

Bank7 Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

President notifies of intention to sell stock

New minor risk - Shareholder dilution

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Bank7 Corp. to Report Q3, 2024 Results on Oct 11, 2024

Upcoming dividend of US$0.24 per share

Bank7 Corp: Earnings Uptrend To Take A Break; Adopting A Hold Rating

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Bank7 (NASDAQ:BSVN) Is Increasing Its Dividend To $0.24

Second quarter dividend increased to US$0.24

Bank7 Corp. Declares Quarterly Cash Dividend, Payable on October 9, 2024

Executive VP & Chief Credit Officer recently sold US$106k worth of stock

Executive VP & Chief Credit Officer notifies of intention to sell stock

Price target increased by 10% to US$39.33

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Bank7 Corp. to Report Q2, 2024 Results on Jul 11, 2024

First quarter dividend of US$0.21 announced

Bank7 Corp. Declares Quarterly Cash Dividend on Common Stock, Payable on July 9, 2024

VP & General Counsel notifies of intention to sell stock

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Increases to CEO Compensation Might Be Put On Hold For Now at Bank7 Corp. (NASDAQ:BSVN)

President recently sold US$203k worth of stock

Bank7 Corp. to Report Q1, 2024 Results on Apr 12, 2024

Bank7: It's Not Wise To Hold Out For Further Upside

Insufficient new directors

Bank7 Corp., Annual General Meeting, May 15, 2024

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Upcoming dividend of US$0.21 per share

Fourth quarter dividend of US$0.21 announced

Bank7 Corp. Declares Quarterly Cash Dividend on Common Stock, Payable on April 4, 2024

President recently sold US$542k worth of stock

President notifies of intention to sell stock

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Bank7 Corp. to Report Q4, 2023 Results on Jan 29, 2024

Price target increased by 14% to US$33.00

Upcoming dividend of US$0.21 per share at 3.3% yield

Executive VP & Chief Credit Officer recently sold US$74k worth of stock

Executive VP & Chief Credit Officer notifies of intention to sell stock

Bank7 (NASDAQ:BSVN) Has Announced A Dividend Of $0.21

President recently sold US$178k worth of stock

Bank7 Corp. Declares Quarterly Cash Dividend on Common Stock Payable on January 4, 2024

Price target decreased by 10% to US$29.00

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Bank7 Corp. to Report Q3, 2023 Results on Oct 26, 2023

Upcoming dividend of US$0.21 per share at 3.4% yield

Bank7 (NASDAQ:BSVN) Is Increasing Its Dividend To $0.21

President recently sold US$352k worth of stock

President notifies of intention to sell stock

Bank7 (NASDAQ:BSVN) Will Pay A Larger Dividend Than Last Year At $0.21

Investor sentiment improves as stock rises 15%

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Bank7 Corp. to Report Q2, 2023 Results on Jul 20, 2023

Upcoming dividend of US$0.16 per share at 2.6% yield

Bank7 (NASDAQ:BSVN) Has Announced That It Will Be Increasing Its Dividend To $0.16

President recently sold US$55k worth of stock

President notifies of intention to sell stock

Price target decreased by 7.8% to US$31.33

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of US$0.16 per share at 1.9% yield

Here's Why We Think Bank7 (NASDAQ:BSVN) Might Deserve Your Attention Today

Vice-Chairman recently sold US$176k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Bank7 Corp. to Report Q4, 2022 Results on Jan 26, 2023

Upcoming dividend of US$0.16 per share

Bank7 (NASDAQ:BSVN) Will Pay A Larger Dividend Than Last Year At $0.16

Bank7's (NASDAQ:BSVN) Shareholders Will Receive A Bigger Dividend Than Last Year

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Bank7 Corp. Declares Quarterly Cash Dividend, Payable on January 5, 2023

Price target increased to US$34.00

Price target increased to US$34.00

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Bank7 Corp. to Report Q3, 2022 Results on Oct 26, 2022

President recently sold US$172k worth of stock

Upcoming dividend of US$0.12 per share

Bank7 (NASDAQ:BSVN) Is Paying Out A Dividend Of $0.12

Bank7 Corp. Declares Quarterly Cash Dividend on Common Stock, Payable on October 7, 2022